THE DEVELOPMENT OF BISCHOFITE ANTI-SCAR GEL COMPOSITION

Abstract

The development of an external gel containing purified bischofite will allow the scars treatment in the stage of prevention and formation due to the effect on various links of pathological wound healing. This study’s aim was the development of a gel with bischofite for the scars prevention and treatment. Bischofite brine from the purified Volgograd deposit was selected as the active pharmaceutical substance. Polymer gelling agents: methylcellulose-100, sodium carboxymethyl cellulose, hydroxymethyl cellulose, aerosil, Tizol®. The QTPP requirements for developed bischofite gel are aimed at effective wound healing and prevention of pathological scarring, which corresponds to the ointments used at the III stage of the wound process. Comprehensive technological studies of model samples of gels with bischofite were carried out: determination of external signs and the application to the skin, smearing, thermal stability and pH, study of osmotic activity and release of bischofite (in terms of magnesium ions). The maximum amount (8 points) was observed in the composition using the Tizol® gel-forming agent, the model sample based on it provided the maximum degree of release, minimal osmotic activity, and good smearing. In addition, Tizol® possesses anti-inflammatory activity. The optimal concentration of the aqueous phase is justified by the assessment of the consistency properties, the spreadability and rheological properties. Thus, as a result the composition of the bischofite gel was developed using Tizol® as a base, containing glycerin as a plasticizer and a moisture agent, the preservative sodium benzoate and purified water.